Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma.
Angiogenesis is considered as an essential process for tumour development and invasion. Previously, we demonstrated that cyclin-dependent kinase inhibition by roscovitine induces a radiosensitization and a synergistic antitumoral effect in human carcinoma but its effect on the microenvironment and tumour angiogenesis remains unknown. Here, we investigated the effect of the combination roscovitine and ionizing radiation (IR) on normal cells in vitro and on tumour angiogenesis in MDA-MB 231 tumour xenografts. We observed that the combination roscovitine and IR induced a marked reduction of angiogenic hot spot and microvascular density in comparison with IR or roscovitine treatments alone. The Ang-2/Tie-2 ratio was increased in presence of reduced vascular endothelial growth factor level suggesting vessel destabilization. In vitro, no radiosensitization effect of roscovitine was found in endothelial, fibroblast, and keratinocyte cells. IR potentiated the antiproliferative effect of roscovitine without inducing apoptosis in endothelial cells. Roscovitine decreased IR-stimulated vascular endothelial growth factor secretion of MDA-MB 231 and endothelial cells. A reduction in the endothelial cells invasion and the capillary-like tube formation in Matrigel were observed following the combination roscovitine and IR. This combined treatment targets angiogenesis resulting in microvessel destabilization without inducing normal cell toxicity.
Maggiorella
L
L
Laboratory of Tumour and Normal Tissues Radiosensitivities, UPRES EA 27-10, Institut Gustave Roussy, Villejuif, France. maggiorella@gmail.com
Aubel
C
C
Haton
C
C
Milliat
F
F
Connault
E
E
Opolon
P
P
Deutsch
E
E
Bourhis
J
J
D017209:Apoptosis; D001483:Base Sequence; D001943:Breast Neoplasms / Q000098:blood supply* / Q000473:pathology; D045744:Cell Line, Tumor; D017077:Culture Media, Conditioned; D017931:DNA Primers; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D009389:Neovascularization, Pathologic; D016133:Polymerase Chain Reaction; D011687:Purines / Q000494:pharmacology*; D011839:Radiation, Ionizing; D000077546:Roscovitine; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D017077:Culture Media, Conditioned; D017931:DNA Primers; D011687:Purines; D042461:Vascular Endothelial Growth Factor A; D000077546:Roscovitine